Integra Lifesciences Holdings (IART) Receivables - Other (2017 - 2025)
Integra Lifesciences Holdings (IART) has disclosed Receivables - Other for 9 consecutive years, with $6.8 million as the latest value for Q4 2025.
- Quarterly Receivables - Other rose 11.36% to $6.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.8 million through Dec 2025, up 11.36% year-over-year, with the annual reading at $6.8 million for FY2025, 11.36% up from the prior year.
- Receivables - Other hit $6.8 million in Q4 2025 for Integra Lifesciences Holdings, up from $4.9 million in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $12.2 million in Q1 2022 to a low of $3.5 million in Q2 2025.
- Historically, Receivables - Other has averaged $8.1 million across 5 years, with a median of $7.9 million in 2021.
- Biggest five-year swings in Receivables - Other: surged 87.98% in 2022 and later crashed 47.29% in 2025.
- Year by year, Receivables - Other stood at $11.4 million in 2021, then decreased by 11.3% to $10.1 million in 2022, then fell by 8.78% to $9.2 million in 2023, then crashed by 33.43% to $6.1 million in 2024, then rose by 11.36% to $6.8 million in 2025.
- Business Quant data shows Receivables - Other for IART at $6.8 million in Q4 2025, $4.9 million in Q3 2025, and $3.5 million in Q2 2025.